(2026). Identifying Predictors of Weight‐Related Outcomes With Fixed‐Dose, Extended‐Release Naltrexone and Bupropion Among Treatment‐Adherent Patients in Phase 3 COR Trials: A Treatment Target Analysis. Obesity Science & Practice.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Identifying Predictors of Weight‐Related Outcomes With Fixed‐Dose, Extended‐Release Naltrexone and Bupropion Among Treatment‐Adherent Patients in Phase 3 COR Trials: A Treatment Target Analysis."
Obesity Science & Practice 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Identifying Predictors of Weight‐Related Outcomes With Fixed‐Dose, Extended‐Release Naltrexone and Bupropion Among Treatment‐Adherent Patients in Phase 3 COR Trials: A Treatment Target Analysis."
Obesity Science & Practice, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.